# Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

> **NCT00607477** · NA · TERMINATED · sponsor: **University of Chicago** · enrollment: 2 (actual)

## Conditions studied

- Treatment Induced Hypertension

## Interventions

- **DRUG:** Minoxidil
- **DRUG:** Hydralazine

## Key facts

- **NCT ID:** NCT00607477
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study has been terminated due to poor accrual.
- **Last updated:** 2014-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607477, "Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00607477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*